Cargando…
Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect
Mycobacterium bovis bacillus Calmette-Guérin (BCG) remains the first treatment option for non-muscle-invasive bladder cancer (BC) patients. In research laboratories, M. bovis BCG is mainly grown in commercially available media supplemented with animal-derived agents that favor its growth, while biom...
Autores principales: | Guallar-Garrido, Sandra, Campo-Pérez, Víctor, Sánchez-Chardi, Alejandro, Luquin, Marina, Julián, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284523/ https://www.ncbi.nlm.nih.gov/pubmed/32423030 http://dx.doi.org/10.3390/microorganisms8050734 |
Ejemplares similares
-
The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium as a Versatile Cell Factory for Lipid Compounds of Therapeutic Interest
por: Campo-Pérez, Víctor, et al.
Publicado: (2022) -
Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment
por: Noguera-Ortega, Estela, et al.
Publicado: (2016) -
Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
por: Bach-Griera, Marc, et al.
Publicado: (2020) -
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment
por: Guallar-Garrido, Sandra, et al.
Publicado: (2022) -
BCG Substrains Change Their Outermost Surface as a Function of Growth Media
por: Guallar-Garrido, Sandra, et al.
Publicado: (2021)